The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
 
Antoine Hollebecque
No Relationships to Disclose
 
Rastislav Bahleda
No Relationships to Disclose
 
Jean Christophe Thery
No Relationships to Disclose
 
Laura Faivre
No Relationships to Disclose
 
Marie-Cécile Le Deley
No Relationships to Disclose
 
Angelo Paci
No Relationships to Disclose
 
Andrea Varga
No Relationships to Disclose
 
Anas Gazzah
No Relationships to Disclose
 
Christophe Massard
No Relationships to Disclose
 
Vianney Poinsignon
No Relationships to Disclose
 
Katty Malekzadeh
No Relationships to Disclose
 
Vincent Ribrag
No Relationships to Disclose
 
ERIC ANGEVIN
No Relationships to Disclose
 
Sophie Postel-Vinay
No Relationships to Disclose
 
Carlos Alberto Gomez-Roca
No Relationships to Disclose
 
Myriam Gharib
No Relationships to Disclose
 
Fabienne Dufour
No Relationships to Disclose
 
Jean-Charles Soria
No Relationships to Disclose
 
Jean-Philippe Spano
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck Serono; MSD Oncology; Pierre Fabre; Roche Pharma AG; Teva; Vifor Pharma